Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NOVORAPID DIN 02245397

Status: Marketed
Holder: NOVO NORDISK CANADA INC
Molecule: INSULIN ASPART
Available to quote

Health Canada record

Active ingredient(s)INSULIN ASPART 100 UNIT
Dosage formSolution
RouteSubcutaneous
ScheduleSCHEDULE D
ClassHuman
ATCA10AB05 INSULIN ASPART
Original market date12-Jun-2002
Current status date12-Jun-2002
SourceHealth Canada DPD

Establishment licence of the holder

Novo Nordisk Canada Inc — licence 100175, currently licensed, last inspection rating C (2023-02-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing INSULIN ASPART

DINProductCompanyFormStrengthStatus
02460408FIASPNOVO NORDISK CANADA INCSolutionINSULIN ASPART 100 UNITMarketed
02460416FIASPNOVO NORDISK CANADA INCSolutionINSULIN ASPART 100 UNITMarketed
02520974KIRSTYBIOCON BIOLOGICS CANADA INCSolutionINSULIN ASPART 100 UNITMarketed
02520982KIRSTYBIOCON BIOLOGICS CANADA INCSolutionINSULIN ASPART 100 UNITApproved
02265435NOVOMIX 30NOVO NORDISK CANADA INCSuspensionINSULIN ASPART 30 UNIT; INSULIN ASPART PROTAMINE 70 UNITMarketed
02244353NOVORAPIDNOVO NORDISK CANADA INCSolutionINSULIN ASPART 100 UNITMarketed
02529254TRURAPISANOFI-AVENTIS CANADA INCSolutionINSULIN ASPART 100 UNITMarketed
02506564TRURAPISANOFI-AVENTIS CANADA INCSolutionINSULIN ASPART 100 UNITMarketed
02506572TRURAPISANOFI-AVENTIS CANADA INCSolutionINSULIN ASPART 100 UNITMarketed
02460424FIASPNOVO NORDISK CANADA INCSolutionINSULIN ASPART 100 UNITDormant
02265443NOVOMIX 30 (FLEXPEN)NOVO NORDISK CANADA INCSuspensionINSULIN ASPART 30 %; INSULIN ASPART PROTAMINE 70 %Cancelled Pre Market
02377209NOVORAPIDNOVO NORDISK CANADA INCSolutionINSULIN ASPART 100 UNITCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
23342001-07-18New Drug Submission (NDS)

International API supply for INSULIN ASPART

6 active FDA Drug Master Files.

Request a quote for NOVORAPID

How to read a Canadian DIN record